Dr Reddys Laboratories Stock Screener | Share Price & Fundamental Analysis
DRREDDY
Pharmaceuticals
Share Price NSE
₹1280.40
▼
-1.90 (-0.15%)
Share Price BSE
₹1280.30
▲
0.55 (0.04%)
Track Dr Reddys Laboratories share price live with TickJournal's free stock screener.
Analyze Dr Reddys Laboratories share price history trends and compare 52-week high low
levels.
Calculate DRREDDY stock fair value using fundamental analysis and view live share price charts.
Determine Dr Reddys Laboratories share intrinsic value and compare it with current DRREDDY share price.
Record your Dr Reddys Laboratories trades in TickJournal's free trading journal and track your portfolio performance.
Dr Reddys Laboratories Market Cap
₹106,866.07 Cr.
DRREDDY P/E Ratio (TTM)
19.34
EPS (TTM)
₹67.89
Dividend Yield
0.62%
Debt to Equity
0.11
DRREDDY 52 Week High
₹1362.70
Dr Reddys Laboratories 52 Week Low
₹1087.90
Operating Margin
23.00%
Profit Margin
17.57%
DRREDDY Revenue (TTM)
₹9,034.00
EBITDA
₹2,503.00
Net Income
₹1,587.00
Total Assets
₹49,427.00
Total Equity
₹33,927.00
Dr Reddys Laboratories Share Price History - Stock Screener Chart
Screen DRREDDY historical share price movements with interactive charts. Analyze price trends and patterns.
Dr Reddys Laboratories Company Profile - Fundamental Screener
Screen Dr Reddys Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for DRREDDY shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE089A01031
Dr Reddys Laboratories Balance Sheet Screener
Screen DRREDDY balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 49,427 | 38,864 | 32,285 | 29,747 | 26,617 | 23,225 | 22,466 | 22,544 | 21,817 | 20,384 |
| Current Assets | 25,018 | 24,805 | 20,426 | 17,782 | 14,550 | 12,599 | 11,110 | 10,498 | 9,684 | 11,794 |
| Fixed Assets | 18,226 | 10,426 | 9,219 | 8,122 | 8,206 | 6,850 | 7,191 | 6,968 | 6,931 | 6,563 |
| Liabilities | ||||||||||
| Total Liabilities | 49,427 | 38,864 | 32,285 | 29,747 | 26,617 | 23,225 | 22,466 | 22,544 | 21,817 | 20,384 |
| Current Liabilities | 2,465 | 1,021 | 427 | 769 | 871 | 412 | 2,545 | 3,079 | 1,135 | 1,467 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 33,927 | 28,255 | 23,286 | 19,212 | 17,642 | 15,599 | 14,024 | 12,572 | 12,262 | 12,570 |
| Share Capital | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 85 |
| Reserves & Surplus | 33,466 | 28,171 | 23,330 | 19,289 | 17,755 | 15,616 | 13,994 | 12,489 | 12,179 | 12,485 |
Dr Reddys Laboratories Income Statement Screener - Profit & Revenue Analysis
Screen Dr Reddys Laboratories income statement and profit fundamentals.
Analyze DRREDDY quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Dr Reddys Laboratories share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9,034 | 8,836 | 9,135 | 8,998 | 7,284 | 7,866 | 8,330 | 8,513 | 6,443 | 6,917 | 7,199 | 7,434 | 5,569 | 6,079 | 6,361 |
| Expenses | 6,531 | 6,399 | 6,818 | 6,866 | 5,283 | 5,566 | 5,962 | 6,108 | 4,781 | 4,696 | 4,894 | 5,214 | 5,024 | 4,292 | 4,433 |
| EBITDA | 2,503 | 2,437 | 2,317 | 2,132 | 2,001 | 2,300 | 2,368 | 2,405 | 1,662 | 2,221 | 2,305 | 2,220 | 545 | 1,787 | 1,928 |
| Operating Profit % | 23.00% | 25.00% | 23.00% | 21.00% | 25.00% | 27.00% | 26.00% | 27.00% | 24.00% | 30.00% | 29.00% | 28.00% | 8.00% | 18.00% | 30.00% |
| Depreciation | 455 | 476 | 505 | 521 | 368 | 381 | 397 | 471 | 316 | 353 | 376 | 374 | 293 | 302 | 309 |
| Interest | 66 | 83 | 91 | 94 | 59 | 60 | 76 | 82 | 35 | 37 | 35 | 39 | 32 | 35 | 31 |
| Profit Before Tax | 2,005 | 1,905 | 1,745 | 1,543 | 1,605 | 1,883 | 1,917 | 1,874 | 1,329 | 1,850 | 1,917 | 1,829 | 259 | 1,468 | 1,614 |
| Tax | 419 | 495 | 408 | 354 | 295 | 490 | 576 | 470 | 369 | 445 | 435 | 448 | 162 | 279 | 499 |
| Net Profit | 1,587 | 1,410 | 1,337 | 1,190 | 1,310 | 1,392 | 1,342 | 1,404 | 960 | 1,405 | 1,482 | 1,381 | 97 | 1,189 | 1,114 |
| EPS | 19.12 | 17.04 | 16.18 | 14.53 | 78.66 | 83.61 | 75.40 | 16.97 | 57.79 | 84.55 | 89.09 | 82.94 | 5.84 | 71.64 | 67.13 |
Dr Reddys Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen DRREDDY cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 4,643 | 4,543 | 5,888 | 2,811 | 3,570 | 2,984 | 2,870 | 1,803 | 2,144 | 3,263 |
| Investing Activities | -5,785 | -4,034 | -4,109 | -2,565 | -2,255 | -495 | -769 | -1,483 | -1,890 | -1,610 |
| Financing Activities | 1,891 | -376 | -2,686 | -242 | -30 | -2,516 | -2,133 | -444 | -369 | -1,700 |
| Net Cash Flow | 749 | 133 | -907 | 3 | 1,286 | -27 | -31 | -124 | -114 | -47 |
Dr Reddys Laboratories Shareholding Pattern Screener
See Dr Reddys Laboratories shareholding pattern with promoter, FII, and DII holdings.
Check Dr Reddys Laboratories promoter holding and ownership changes for DRREDDY on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 26.64% | 26.64% | 26.64% | 26.64% | 26.65% | 26.65% | 26.64% | 26.64% |
| FII Holding | 37.29% | 36.36% | 35.52% | 33.20% | 44.49% | 42.27% | 41.75% | 40.08% |
| DII Holding | 25.62% | 26.74% | 27.98% | 30.44% | 18.31% | 20.73% | 21.48% | 22.90% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 8.20% | 8.04% | 7.56% | 7.65% | 8.25% | 8.07% | 8.07% | 8.07% |
| Other Holding | 2.25% | 2.22% | 2.30% | 2.07% | 2.30% | 2.29% | 2.06% | 2.30% |
| Shareholder Count | 459,605 | 451,929 | 449,216 | 455,243 | 255,500 | 267,694 | 310,403 | 403,669 |
Dr Reddys Laboratories Share Dividend Screener - Share Yield Analysis
Check Dr Reddys Laboratories dividend history with payout and yield data.
View Dr Reddys Laboratories dividend details including ex-dates and amounts for DRREDDY stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹8.00 | 0.62% |
| 2024-March | ₹40.00 | 3.50% |
| 2023-March | ₹40.00 | 3.25% |
| 2022-March | ₹30.00 | 3.24% |
| 2021-March | ₹25.00 | 2.91% |
| 2020-March | ₹25.00 | 2.77% |
| 2019-March | ₹20.00 | 3.20% |
| 2018-March | ₹20.00 | 3.60% |
| 2017-March | ₹20.00 | 4.81% |
Dr Reddys Laboratories Stock Index Membership
See which indices include Dr Reddys Laboratories stock.
Check DRREDDY index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Dr Reddys Laboratories Market Events Screener - Corporate Actions
Get Dr Reddys Laboratories corporate actions including splits, bonuses, and buybacks.
Check Dr Reddys Laboratories stock events that may affect DRREDDY share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-01-21 | 2026-01-21 | Quarterly Result Announcement | NA | -9.12% |
| 2025-10-24 | 2025-10-24 | Quarterly Result Announcement | NA | -3.20% |
| 2025-07-24 | 2025-07-24 | Annual General Meeting | NA | 8.66% |
| 2025-07-23 | 2025-07-23 | Quarterly Result Announcement | NA | -6.42% |
| 2025-07-10 | 2025-07-10 | Dividend | ₹ 8.00 /share | 10.57% |
| 2025-05-09 | 2025-05-09 | Quarterly Result Announcement | NA | -3.30% |
| 2025-01-23 | 2025-01-23 | Quarterly Result Announcement | NA | -3.53% |
| 2024-11-05 | 2024-11-05 | Quarterly Result Announcement | NA | -3.20% |
| 2024-10-28 | 2024-07-27 | Split | 1:5 | 0.00% |
| 2024-07-29 | 2024-07-29 | Annual General Meeting | NA | 9.51% |
| 2024-07-16 | 2024-07-17 | Dividend | ₹ 40.00 /share | 5.60% |
| 2023-07-11 | 2023-07-12 | Dividend | ₹ 40.00 /share | 4.71% |
| 2022-07-11 | 2022-07-13 | Dividend | ₹ 30.00 /share | 14.73% |
| 2021-07-09 | 2021-07-13 | Dividend | ₹ 25.00 /share | 3.54% |
Dr Reddys Laboratories Competitors Screener - Peer Comparison
Screen DRREDDY competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 413,741 | 37.53 | 54,729 | 9.71% | 10,980 | 58.16 |
| Divis Laboratories | 167,006 | 67.40 | 9,712 | 18.67% | 2,191 | 53.89 |
| Torrent Pharmaceuticals | 143,558 | 62.90 | 11,539 | 6.99% | 1,911 | 66.58 |
| Cipla | 108,330 | 23.68 | 28,410 | 7.12% | 5,291 | 43.41 |
| Dr Reddys Laboratories | 106,866 | 19.34 | 33,741 | 16.73% | 5,725 | 60.10 |
| Lupin | 101,382 | 21.81 | 22,910 | 13.74% | 3,306 | 57.52 |
| Zydus Life Science | 90,637 | 18.06 | 23,511 | 18.55% | 4,615 | 49.52 |
| Mankind Pharma | 83,564 | 46.65 | 12,744 | 20.90% | 2,007 | 38.95 |
| Aurobindo Pharma | 67,303 | 19.60 | 32,346 | 9.43% | 3,484 | 47.48 |
| Alkem Laboratories | 64,469 | 26.53 | 13,458 | 3.70% | 2,216 | 37.57 |
Dr Reddys Laboratories Company Announcements - News Screener
Screen DRREDDY latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-02-19 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-02-18 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | View |
| 2026-02-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-02-13 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2026-02-09 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2026-02-02 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2026-01-27 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2026-01-24 | Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 | View |
| 2026-01-22 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-01-21 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2026-01-21 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2026-01-21 | Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025 | View |
| 2026-01-21 | Board Meeting Outcome for Outcome Of Board Meeting | View |
| 2026-01-14 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-01-10 | Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 | View |
| 2026-01-08 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-01-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2026-01-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-01-01 | Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 | View |
| 2025-12-31 | Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 | View |